Business Expansion into the Clinical Trials Sector
First written in FY2023-Q1. 3 of 6 entries say "Advanced", first in FY2023-Q2. Latest entry: 2026-09-10.
5 other companies' latest entry also says "Advanced".
- FY2024DroppedAnnual report
「Under a capital and business alliance agreement with the parent company, OMRON Corporation, the company is also working jointly to develop preventive solutions and expand its overseas business.」
The management strategy and business description in this filing contain no reference to providing services in the clinical trials field through リアルワールドデータ株式会社 and other companies, which had been described through the previous filing. - FY2023-Q3RestatedAnnual report
「In addition to the business expansion described above, the company substantially expanded its medical institution-derived data, including by making リアルワールドデータ株式会社 a subsidiary in July 2022, and began efforts to provide services in new fields such as clinical trials.」
The company reiterated the expansion of medical institution-derived data through the acquisition of リアルワールドデータ株式会社 and other companies as subsidiaries, as well as the start of service provision in new fields such as clinical trials. - FY2023-Q2AdvancedAnnual report
「During the six months ended the second quarter, the company substantially expanded its medical institution-sourced data by making Real World Data Co., Ltd. and other companies subsidiaries, and began efforts to provide services in new areas such as clinical trials.」
Following the acquisition of リアルワールドデータ株式会社 and other companies as subsidiaries, the company began efforts to provide services in new fields such as clinical trials. - FY2023-Q1First statedAnnual report
「The objective is to expand the existing business and enter the clinical trials field by using electronic medical record and other medical information data, primarily from large medical institutions.」
For the purpose of acquiring リアルワールドデータ株式会社, the company stated for the first time its policy of expanding its existing business using electronic medical record and other data, as well as broadening its business into the clinical trials field.